← Back to Search

Anti-epileptic Drug

BHV-7000 for Epilepsy

Phase 2
Waitlist Available
Research Sponsored by Biohaven Therapeutics Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 52 weeks
Awards & highlights
No Placebo-Only Group

Summary

"This trial is investigating whether BHV-7000 is safe and well-tolerated in adults with difficult-to-treat focal onset epilepsy."

Who is the study for?
This trial is for adults with refractory focal onset epilepsy who have finished the double-blind phase of previous BHV-7000 studies. Women able to bear children must test negative for pregnancy before starting.
What is being tested?
The study is testing the long-term safety and tolerability of a medication called BHV-7000 in individuals with difficult-to-treat epilepsy that starts in one area of the brain.
What are the potential side effects?
While specific side effects are not listed, 'safety and tolerability' suggest monitoring for any adverse reactions or discomfort caused by BHV-7000 over an extended period.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 52 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants With Deaths, Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and moderate or severe AEs
Number of Subjects with Clinically Significant Laboratory Abnormalities

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: BHV-7000 75 mgExperimental Treatment1 Intervention
Group II: BHV-7000 50 mgExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Biohaven Therapeutics Ltd.Lead Sponsor
11 Previous Clinical Trials
4,036 Total Patients Enrolled
3 Trials studying Epilepsy
1,022 Patients Enrolled for Epilepsy
~440 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top